Tomás P Griffin

21PUBLICATIONS
56CO-AUTHORS
Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Poverty, inclusivity and wellbeingAllergyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 20, 2024
The impact of social deprivation on development and progression of diabetic kidney disease.

Caoimhe Casey, Claire M Buckley, Patricia M Kearney

|May 25, 2024
Effect of Immunosuppression on the Immune Response to SARS-CoV-2 Infection and Vaccination.

Emma J Leacy, Jia Wei Teh, Aoife M O'Rourke

|Dec 01, 2023
Authors' Reply: Cell Therapies in Diabetic Kidney Disease: Is It Time for Clinical Translation?

Norberto Perico, Matthew D Griffin, Federica Casiraghi

|Aug 10, 2023
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).

Norberto Perico, Giuseppe Remuzzi, Matthew D Griffin

Pageof 4